Neuberger Berman Group’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-152
Closed -$21.2K 1893
2023
Q2
$21.2K Buy
152
+50
+49% +$6.42K ﹤0.01% 1775
2023
Q1
$9.24K Hold
102
﹤0.01% 1787
2022
Q4
$13.9K Hold
102
﹤0.01% 1760
2022
Q3
$88K Hold
102
﹤0.01% 1778
2022
Q2
$44K Hold
102
﹤0.01% 1811
2022
Q1
$64K Hold
102
﹤0.01% 1863
2021
Q4
$90K Sell
102
-1,992
-95% -$2.09M ﹤0.01% 1867
2021
Q3
$2.65M Sell
2,094
-252
-11% -$305K ﹤0.01% 1107
2021
Q2
$2.84M Buy
2,346
+765
+48% +$1.03M ﹤0.01% 1103
2021
Q1
$2.1M Buy
1,581
+651
+70% +$922K ﹤0.01% 1141
2020
Q4
$1.25M Sell
930
-1,861
-67% -$2.13M ﹤0.01% 1204
2020
Q3
$2.9M Buy
+2,791
New +$2.92M ﹤0.01% 984

Other funds holding CANO

Neuberger Berman Group's CANO Position: Q3 2023 in Review

Neuberger Berman Group sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 152 shares — an estimated $21.2K sold.

Neuberger Berman Group first reported a position in CANO in Q3 2020 and held it in 12 quarters. The position peaked at $2.9M in Q3 2020. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Neuberger Berman Group reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 152 Cano Health, Inc. shares in Q3 2023, an estimated $21.2K.
  • Neuberger Berman Group first reported a position in Cano Health, Inc. in Q3 2020 and held it in 12 quarters.
  • Neuberger Berman Group's Cano Health, Inc. position peaked at $2.9M in Q3 2020.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Neuberger Berman Group's 13F filing for Q3 2023, filed 14 Nov 2023.